Sort
35,931 grants matching “parkinsons”
Peripheral Biomarkers for Early Diagnosis of Mixed Pathologies in AD/ADRD
$756,004Shu G Chen · University Of Alabama At Birmingham · R01 · FY2023 · AG
Imaging Brain Signal Transduction In Vivo With Radiolabeled Arachidonic Acid
$755,856Stanley I Rapoport · Aging · Z01 · FY2007 · AG
Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease.
$755,842Virendra R Mishra · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · NS
Early development of small molecule neuroprotectants.
$755,830Corinne Ida Lasmezas · Scripps Florida · R01 · FY2018 · NS
Deep Brain Stimulation for Chronic Auditory Hallucinations in Treatment-Resistant Schizophrenia: an early-stage clinical trial
$755,643Nicola G Cascella · Johns Hopkins University · U01 · FY2024 · MH
Vectorial Folding of Large, Multidomain Proteins
$755,643Piotr E Marszalek · Duke University · · FY2015 · BIO
Multiplexed Quantification of the Protein Poly-ADP-Ribosylation Landscape in C9ORF72-ALS/FTD
$755,606Yonghao Yu · Columbia University Health Sciences · R01 · FY2024 · NS
Neurobiological Underpinnings of Placebo Response in Depression
$755,429Maurizio Fava · Massachusetts General Hospital · R01 · FY2017 · MH
Skin biomarkers for diagnosing and characterizing AD and ADRD
$755,388Allison L Kraus · Case Western Reserve University · R01 · FY2022 · AG
Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
$755,300Catherine L. Gallagher · University Of Wisconsin-Madison · R01 · FY2024 · AG
Neuroimaging response inhibition and salience attribution changes during mindfulness-based treatment of human heroin addiction
$754,896Rita Z Goldstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AT
Neuroimaging response inhibition and salience attribution changes during mindfulness-based treatment of human heroin addiction
$754,750Rita Z Goldstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AT
Neuroimaging response inhibition and salience attribution changes during mindfulness-based treatment of human heroin addiction
$754,720Rita Z Goldstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AT
Developing a systems biology platform for predicting, preventing, and treating drug side effects
$754,478Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2020 · GM
Circuit-Inspired Strategies to Restore Basal Ganglia Function in Mouse Models of Parkinsonâs Disease
$754,344Aryn Hilary Gittis · Carnegie-Mellon University · R35 · FY2024 · NS
EDUCATION AND OUTREACH ACTIVITIES FOR NINDS; SUPPORT- PROFESSIONAL: OTHER
$754,200Jean Song · · N02 · FY2017 · NS
Brainstem-based imaging biomarkers of premanifest synucleinopathy
$754,094Marta Bianciardi · Massachusetts General Hospital · R01 · FY2022 · AG
EMBRYONIC DOPAMINE CELL IMPLANTS FOR PARKINSONISM
$754,094University Of Colorado Denver · R01 · FY2001 · NS
Modeling mTOR network dynamics to achieve optimal drug rescue of congenital mTORopathies
$754,066Stephen Edward Paucha Smith · Seattle Children'S Hospital · R01 · FY2025 · NS
Establishment of a UMDNJ NeuroProteomics Core Facility
$753,839Univ Of Med/Dent Of Nj-Nj Medical School · P30 · FY2004 · NS
Risk Factors for Pathologic Markers of Parkinson Disease
$753,822Pacific Health Research Institute · R01 · FY2004 · NS
Exosomal transport of brain-derived proteins to the blood in Alzheimer disease
$753,799Jing Zhang · University Of Washington · R56 · FY2017 · AG
Immunoregulatory Defects In Inflammatory Bowel Disease
$753,017Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Protein co-pathologies in Alzheimer's Disease and Related Dementias
$752,589Georgina Aldridge · University Of Iowa · R01 · FY2025 · AG
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy
$752,390S. Ali Fatemi · Hugo W. Moser Res Inst Kennedy Krieger · R61 · FY2025 · NS